Ubs Group Ag Day One Biopharmaceuticals, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 114,637 shares of DAWN stock, worth $1.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

114,637

Previous 70,083 63.57%

Holding current value

$1.47 Million

Previous $965,000 65.39%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$12.72 - $16.03 $566,726 - $714,200	44,554 Added 63.57%	114,637 $1.6 Million
Q2 2024 Aug 13, 2024	SELL	$12.03 - $17.69 $1.13 Million - $1.66 Million	-93,935 Reduced 57.27%	70,083 $965,000
Q1 2024 May 13, 2024	BUY	$13.56 - $17.46 $506,845 - $652,619	37,378 Added 29.52%	164,018 $2.71 Million
Q4 2023 Feb 09, 2024	BUY	$9.68 - $15.37 $994,707 - $1.58 Million	102,759 Added 430.3%	126,640 $1.85 Million
Q3 2023 Nov 09, 2023	BUY	$11.22 - $14.86 $127,212 - $168,482	11,338 Added 90.39%	23,881 $293,000
Q2 2023 Aug 11, 2023	SELL	$11.74 - $14.47 $672,960 - $829,449	-57,322 Reduced 82.05%	12,543 $149,000
Q1 2023 May 12, 2023	SELL	$12.75 - $23.41 $764,898 - $1.4 Million	-59,992 Reduced 46.2%	69,865 $934,000
Q4 2022 Feb 08, 2023	BUY	$18.77 - $22.0 $2.03 Million - $2.38 Million	108,251 Added 501.02%	129,857 $2.79 Million
Q3 2022 Nov 10, 2022	BUY	$16.44 - $26.57 $291,892 - $471,750	17,755 Added 461.05%	21,606 $432,000
Q2 2022 Aug 10, 2022	BUY	$5.72 - $17.9 $22,027 - $68,932	3,851 New	3,851 $69,000
Q1 2022 May 16, 2022	SELL	$9.12 - $17.47 $55,659 - $106,619	-6,103 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$15.65 - $26.33 $94,588 - $159,138	6,044 Added 10244.07%	6,103 $103,000
Q3 2021 Nov 15, 2021	BUY	$20.0 - $27.92 $1,180 - $1,647	59 New	59 $1,000

Others Institutions Holding DAWN

# of Institutions

178

Shares Held

84M

Call Options Held

144K

Put Options Held

218K

View Full List

About Day One Biopharmaceuticals, Inc.

Ticker DAWN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,461,104
Market Cap $940M
Description
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...

More about DAWN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account